Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,601 to 1,620 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Target-Directed Approaches for Screening Small Molecules against RNA Targets. | SLAS Discov | 2020 | 32419578 | PubTator, text mining | PubMed |
| Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy. | Genet Med | 2020 | 32418989 | PubTator, text mining | PubMed |
| Evaluation of Genotypes and Epidemiology of Spinal Muscular Atrophy in Greece: A Nationwide Study Spanning 24 Years. | J Neuromuscul Dis | 2020 | 32417790 | PubTator, text mining | PubMed |
| Mutation-Directed Therapeutics for Neurofibromatosis Type I. | Mol Ther Nucleic Acids | 2020 | 32408052 | PubTator, text mining | PubMed |
| Rational Design of an Activatable Reporter for Quantitative Imaging of RNA Aberrant Splicing In Vivo. | Mol Ther Methods Clin Dev | 2020 | 32405512 | PubTator, text mining | PubMed |
| New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand? | Int J Mol Sci | 2020 | 32392694 | PubTator, text mining | PubMed |
| Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation. | Front Pharmacol | 2020 | 32390854 | PubTator, text mining | PubMed |
| A survey of transcripts generated by spinal muscular atrophy genes. | Biochim Biophys Acta Gene Regul Mech | 2020 | 32387331 | PubTator, text mining | PubMed |
| SMN-deficiency disrupts SERCA2 expression and intracellular Ca2+ signaling in cardiomyocytes from SMA mice and patient-derived iPSCs. | Skelet Muscle | 2020 | 32384912 | PubTator, text mining | PubMed |
| Non-Histone Arginine Methylation by Protein Arginine Methyltransferases. | Curr Protein Pept Sci | 2020 | 32379587 | PubTator, text mining | PubMed |
| Motor unit number index in children with later-onset spinal muscular atrophy. | Muscle Nerve | 2020 | 32369629 | PubTator, text mining | PubMed |
| Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach. | Genet Med | 2020 | 32366966 | PubTator, text mining | PubMed |
| VRK1 (Y213H) homozygous mutant impairs Cajal bodies in a hereditary case of distal motor neuropathy. | Ann Clin Transl Neurol | 2020 | 32365420 | PubTator, text mining | PubMed |
| Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing. | J Am Chem Soc | 2020 | 32364710 | PubTator, text mining | PubMed |
| The Small-Molecule Flunarizine in Spinal Muscular Atrophy Patient Fibroblasts Impacts on the Gemin Components of the SMN Complex and TDP43, an RNA-Binding Protein Relevant to Motor Neuron Diseases. | Front Mol Biosci | 2020 | 32363199 | PubTator, text mining | PubMed |
| Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy. | J Neurol | 2020 | 32361837 | PubTator, text mining | PubMed |
| RNA-Targeted Therapies and High-Throughput Screening Methods. | Int J Mol Sci | 2020 | 32340368 | PubTator, text mining | PubMed |
| Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy. | EBioMedicine | 2020 | 32339936 | PubTator, text mining | PubMed |
| Spinal muscular atrophy caused by a novel Alu-mediated deletion of exons 2a-5 in SMN1 undetectable with routine genetic testing. | Mol Genet Genomic Med | 2020 | 32337852 | PubTator, text mining | PubMed |
| Clinical utility of multigene analysis in over 25,000 patients with neuromuscular disorders. | Neurol Genet | 2020 | 32337338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=81